Treatment.com AI Inc. Stock

Equities

TRUE

CA8949421017

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 03:53:13 2024-04-26 pm EDT 5-day change 1st Jan Change
0.69 CAD -1.43% Intraday chart for Treatment.com AI Inc. -2.82% +62.35%
Sales 2021 - Sales 2022 - Capitalization 3.31M 4.53M
Net income 2021 -13M -17.77M Net income 2022 -3M -4.1M EV / Sales 2021 -
Net cash position 2021 917K 1.25M Net Debt 2022 564K 771K EV / Sales 2022 -
P/E ratio 2021
-3.84 x
P/E ratio 2022
-0.87 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 95.22%
More Fundamentals * Assessed data
Dynamic Chart
Treatment.com AI Inc. Announces New Additions to Its Medical Education Suite CI
Treatment.com AI Partnering With aiXplain Inc. to Extend Access to its Global Library of Medicine MT
Treatment.com AI Inc.'s AI Medical Information Support Platform Uses in the Objective Structured Clinical Examination CI
Treatment.com AI Inc. announced that it has received CAD 2.9082 million in funding CI
Treatment.com AI Inc. announced that it expects to receive CAD 2 million in funding CI
Treatment.com AI Inc. Announces the Resignation of John Fraser from the Board of Directors CI
Treatment.Com Ai Inc. Appoints David Worner as Chief Financial Officer CI
Treatment.com AI Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Treatment.com International Inc. will Change its Name to Treatment.com AI Inc CI
Treatment.Com International Inc. Appoints Kevin Peterson as Chief Medical Officer CI
Treatment.Com International Inc. Appoints Dr. Essam Hamza, MD as Chief Executive Officer CI
Treatment.Com International Inc. Appoints Dr. Essam Hamza, Md to its Board of Directors CI
Treatment.Com International Inc. announced that it has received CAD 0.37125 million in funding CI
Treatment.Com International Inc. announced that it has received CAD 1 million in funding CI
Treatment.Com International Inc. announced that it expects to receive CAD 0.5 million in funding CI
More news
1 day-1.43%
1 week-2.82%
Current month+15.00%
1 month+21.05%
3 months+27.78%
6 months+40.82%
Current year+62.35%
More quotes
1 week
0.68
Extreme 0.68
0.76
1 month
0.58
Extreme 0.58
0.76
Current year
0.44
Extreme 0.44
0.76
1 year
0.10
Extreme 0.1
1.20
3 years
0.10
Extreme 0.1
63.00
5 years
0.10
Extreme 0.1
63.00
10 years
0.10
Extreme 0.1
63.00
More quotes
Managers TitleAgeSince
Founder 70 15-12-31
Chief Executive Officer 53 23-10-16
Director of Finance/CFO 45 Feb. 04
Members of the board TitleAgeSince
Director/Board Member 45 21-01-17
Chief Executive Officer 53 23-10-16
Founder 70 15-12-31
More insiders
Date Price Change Volume
24-04-26 0.69 -1.43% 40,955
24-04-25 0.7 -4.11% 132,900
24-04-24 0.73 +4.29% 61,750
24-04-23 0.7 -2.78% 54,330
24-04-22 0.72 +1.41% 206,525

Delayed Quote Canadian Securities Exchange, April 26, 2024 at 03:53 pm EDT

More quotes
Treatment.com AI Inc., through its wholly owned subsidiary, Treatment.com Inc., is in the business of providing personalized health care information. The Company has developed a personalized healthcare artificial intelligence (AI) engine, the Global Library of Medicine (GLM), which is engaged in providing clinical information and support to all healthcare professionals. The GLM delivers over 92% accuracy on first diagnosis as well as providing recommended tests (physical and lab), x-rays, and billing codes. Its solutions include medical education solution, medical clinic solution and clinical advisor solution. It also focuses on the next generation of healthcare professionals supporting medical and nursing schools, who utilize the GLM to help improve the clinical skills of their students. It is also focused on using AI for utilizing its GLM platform to bring the possibility of health equity and inclusion for disenfranchised communities.
More about the company